This inventor holds 1 USPTO granted patent. Top assignees: Michigan State University, University of Michigan. Active years: 2020.
Company Filing History:
1 out of 1,437 
1 out of 3,519 
Years Active: 2020
Title: The Innovative Contributions of Dylan Kahl
Introduction
Dylan Kahl is an accomplished inventor based in Ann Arbor, MI. He has made significant contributions to the field of gene transcription, particularly in the context of treating diseases such as cancer and fibrosis. His work exemplifies the intersection of scientific research and practical application.
Latest Patents
Dylan Kahl holds a patent titled "Inhibitors of Rho/MRTF/SRF-mediated gene transcription and methods for use of the same." This patent discloses inhibitors of Rho/MRTF/SRF-mediated gene transcription, along with methods for their use in treating or preventing diseases. The patent specifically details compounds of Formula (I) and their pharmaceutically acceptable salts, where the substituents are as described.
Career Highlights
Throughout his career, Dylan has worked with prestigious institutions such as the University of Michigan and Michigan State University. His experience in these academic environments has allowed him to develop and refine his innovative ideas, contributing to advancements in medical research.
Collaborations
Dylan has collaborated with notable colleagues, including Erika Mathes Lisabeth and Scott D Larsen. These partnerships have fostered a collaborative environment that enhances the potential for groundbreaking discoveries.
Conclusion
Dylan Kahl's work in gene transcription inhibitors showcases his dedication to addressing critical health challenges. His innovative spirit and collaborative efforts continue to pave the way for future advancements in medical science.